PPARG and cystic kidney disease: Pioglitazone; a well-known anti-diabetic drug that is a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, has been found to suppress the development of renal cyst in the preclinical studies via different mechanisms which inarguably suggests its pleiotropy.